News file for: Jiangsu Chia-tai Tianqing Pharmaceutical Co. Ltd.

BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China

BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China

BioLineRx has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharma to commercialize BL-8030 in China.